|
1
|
GBD 2019 Viewpoint Collaborators, . Five
insights from the global burden of disease study 2019. Lancet.
396:1135–1159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah R, Patel T and Freedman JE:
Circulating extracellular vesicles in human disease. N Engl J Med.
379:958–966. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Théry C, Witwer KW, Aikawa E, Alcaraz JM,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extracellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sahoo S, Adamiak M, Mathiyalagan P,
Kenneweg F, Kafert-Kasting S and Thum T: Therapeutic and diagnostic
translation of extracellular vesicles in cardiovascular diseases.
Circulation. 143:1426–1449. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin-Ventura JL, Roncal C, Orbe J and
Blanco-Colio LM: Role of extracellular vesicles as potential
diagnostic and/or therapeutic biomarkers in chronic cardiovascular
diseases. Front Cell Dev Biol. 10:8138852022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi Y, Zhang H, Huang S, Yin L, Wang F,
Luo P and Huang H: Epigenetic regulation in cardiovascular disease:
Mechanisms and advances in clinical trials. Signal Transduct Target
Ther. 7:2002022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khan MI, Alsayed RKME, Choudhry H and
Ahmad A: Exosome-mediated response to cancer therapy: Modulation of
epigenetic machinery. Int J Mol Sci. 23:62222022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nasir A, Bullo MMH, Ahmed Z, Imtiaz A,
Yaqoob E, Jadoon M, Ahmed H, Afreen A and Yaqoob S: Nutrigenomics:
Epigenetics and cancer prevention: A comprehensive review. Crit Rev
Food Sci Nutr. 60:1375–1387. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schiano C, Benincasa G, Franzese M, Della
Mura N, Pane K, Salvatore M and Napoli C: Epigenetic-sensitive
pathways in personalized therapy of major cardiovascular diseases.
Pharmacol Ther. 210:1075142020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hulshoff MS, Xu X, Krenning G and Zeisberg
EM: Epigenetic regulation of Endothelial-to-mesenchymal transition
in chronic heart disease. Arterioscler Thromb Vasc Biol.
38:1986–1996. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang W and Wang J: Exosomes and their
noncoding RNA cargo are emerging as new modulators for diabetes
mellitus. Cells. 8:8532019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao H, Im H, Castro CM, Breakefield X,
Weissleder R and Lee H: New technologies for analysis of
extracellular vesicles. Chem Rev. 118:1917–1950. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raiborg C and Stenmark H: The ESCRT
machinery in endosomal sorting of ubiquitylated membrane proteins.
Nature. 458:445–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Li S, Li L, Li M, Guo C, Yao J
and Mi S: Exosome and exosomal microRNA: Trafficking, sorting, and
function. Genomics Proteomics Bioinformatics. 13:17–24. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poddar S, Kesharwani D and Datta M:
Interplay between the miRNome and the epigenetic machinery:
Implications in health and disease. J Cell Physiol. 232:2938–2945.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Petrovic N and Ergun S: miRNAs as
potential treatment targets and treatment options in cancer. Mol
Diagn Ther. 22:157–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lou Z, Zhou R, Su Y, Liu C, Ruan W, Jeon
CO, Han X, Lin C and Jia B: Minor and major circRNAs in virus and
host genomes. J Microbiol. 59:324–331. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang T, Long T, Du T, Chen Y, Dong Y and
Huang ZP: Circle the cardiac remodeling with circRNAs. Front
Cardiovasc Med. 8:7025862021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hall IF, Climent M, Viviani Anselmi C,
Papa L, Tragante V, Lambroia L, Farina FM, Kleber ME, März W,
Biguori C, et al: rs41291957 controls miR-143 and miR-145
expression and impacts coronary artery disease risk. EMBO Mol Med.
13:e140602021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang F, Chen Q, Wang W, Ling Y, Yan Y and
Xia P: Hepatocyte-derived extracellular vesicles promote
endothelial inflammation and atherogenesis via microRNA-1. J
Hepatol. 72:156–166. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hou Z, Qin X, Hu Y, Zhang X, Li G, Wu J,
Li J, Sha J, Chen J, Xia J, et al: Longterm Exercise-derived
exosomal miR-342-5p: A novel exerkine for cardioprotection. Circ
Res. 124:1386–1400. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang YJ, Li YS, Wu CC, Wang KC, Huang TC,
Chen Z and Chien S: Extracellular MicroRNA-92a mediates endothelial
Cell-macrophage communication. Arterioscler Thromb Vasc Biol.
39:2492–2504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sindi HA, Russomanno G, Satta S,
Abdul-Salam VB, Jo KB, Qazi-Chaudhry B, Ainscough AJ, Szulcek R,
Jan Bogaard H, Morgan CC, et al: Therapeutic potential of
KLF2-induced exosomal microRNAs in pulmonary hypertension. Nat
Commun. 11:11852020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miao Y, Ajami NE, Huang TS, Lin FM, Lou
CH, Wang YT, Li S, Kang J, Munkacsi H, Maurya MR, et al:
Enhancer-associated long non-coding RNA LEENE regulates endothelial
nitric oxide synthase and endothelial function. Nat Commun.
9:2922018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang K, Liu CY, Zhou LY, Wang JX, Wang M,
Zhao B, Zhao WK, Xu S, Fan LH, Zhang XJ, et al: APF lncRNA
regulates autophagy and myocardial infarction by targeting
miR-188-3p. Nat Commun. 6:67792015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang H, Su X, Wu Q, Shan H, Lv L, Yu T,
Zhao X, Sun J, Yang R, Zhang L, et al: LncRNA 2810403D21Rik/Mirf
promotes ischemic myocardial injury by regulating autophagy through
targeting Mir26a. Autophagy. 16:1077–1091. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Viereck J, Bührke A, Foinquinos A,
Chatterjee S, Kleeberger JA, Xiao K, Janssen-Peters H, Batkai S,
Ramanujam D, Kraft T, et al: Targeting muscle-enriched long
non-coding RNA H19 reverses pathological cardiac hypertrophy. Eur
Heart J. 41:3462–3474. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Omura J, Habbout K, Shimauchi T, Wu WH,
Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Gagnon K,
Mazoyer F, et al: Identification of long noncoding RNA H19 as a new
biomarker and therapeutic target in right ventricular failure in
pulmonary arterial hypertension. Circulation. 142:1464–1484. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hua X, Wang YY, Jia P, Xiong Q, Hu Y,
Chang Y, Lai S, Xu Y, Zhao Z, Song J, et al: Multi-level
transcriptome sequencing identifies COL1A1 as a candidate marker in
human heart failure progression. BMC Med. 18:22020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mao YY, Wang JQ, Guo XX, Bi Y and Wang CX:
Circ-SATB2 upregulates STIM1 expression and regulates vascular
smooth muscle cell proliferation and differentiation through
miR-939. Biochem Biophys Res Commun. 505:119–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen L, Hu Y, Lou J, Yin S, Wang W, Wang
Y, Xia Y and Wu W: CircRNA-0044073 is upregulated in
atherosclerosis and increases the proliferation and invasion of
cells by targeting miR-107. Mol Med Rep. 19:3923–3932.
2019.PubMed/NCBI
|
|
35
|
Sygitowicz G and Sitkiewicz D: Involvement
of circRNAs in the development of heart failure. Int J Mol Sci.
23:141292022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu N, Li C, Xu B, Xiang Y, Jia X, Yuan Z,
Wu L, Zhong L and Li Y: Circular RNA mmu_circ_0005019 inhibits
fibrosis of cardiac fibroblasts and reverses electrical remodeling
of cardiomyocytes. BMC Cardiovasc Disord. 21:3082021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang M, Wang Z, Cheng Q, Wang Z, Lv X,
Wang Z and Li N: Circular RNA (circRNA) CDYL induces myocardial
regeneration by ceRNA after myocardial infarction. Med Sci Monit.
26:e9231882020.PubMed/NCBI
|
|
38
|
Leimena C and Qiu H: Non-Coding RNA in the
pathogenesis, progression and treatment of hypertension. Int J Mol
Sci. 19:9272018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun Y, Yang Z, Zheng B, Zhang XH, Zhang
ML, Zhao XS, Zhao HY, Suzuki T and Wen JK: A novel regulatory
mechanism of smooth muscle α-Actin expression by
NRG-1/circACTA2/miR-548f-5p Axis. Circ Res. 121:628–635. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang K, Zhou Q, Qiao B, Shao B, Hu S, Wang
G, Yuan W and Sun Z: Exosome-derived noncoding RNAs: Function,
mechanism, and application in tumor angiogenesis. Mol Ther Nucleic
Acids. 27:983–997. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qian Z, Shen Q, Yang X, Qiu Y and Zhang W:
The role of extracellular vesicles: An epigenetic view of the
cancer microenvironment. Biomed Res Int. 2015:6491612015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Radhakrishna U, Albayrak S, Zafra R, Baraa
A, Vishweswaraiah S, Veerappa AM, Mahishi D, Saiyed N, Mishra NK,
Guda C, et al: Placental epigenetics for evaluation of fetal
congenital heart defects: Ventricular Septal Defect (VSD). PLoS
One. 14:e02002292019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li S, Geng Q, Chen H, Zhang J, Cao C,
Zhang F, Song J, Liu C and Liang W: The potential inhibitory
effects of miR-19b on vulnerable plaque formation via the
suppression of STAT3 transcriptional activity. Int J Mol Med.
41:859–867. 2018.PubMed/NCBI
|
|
44
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Q, Song XW, Zou J, Wang GK, Kremneva E,
Li XQ, Zhu N, Sun T, Lappalainen P, Yuan WJ, et al: Attenuation of
microRNA-1 derepresses the cytoskeleton regulatory protein
twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci.
123:2444–2452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Heidersbach A, Saxby C, Carver-Moore K,
Huang Y, Ang YS, de Jong PJ, Ivey KN and Srivastava D: microRNA-1
regulates sarcomere formation and suppresses smooth muscle gene
expression in the mammalian heart. Elife. 2:e013232013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Benzoni P, Nava L, Giannetti F, Guerini G,
Gualdoni A, Bazzini C, Milanesi R, Bucchi A, Baruscotti M and
Barbuti A: Dual role of miR-1 in the development and function of
sinoatrial cells. J Mol Cell Cardiol. 157:104–112. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of MicroRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zernecke A, Bidzhekov K, Noels H,
Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh
MN, Lutgens E, et al: Delivery of microRNA-126 by apoptotic bodies
induces CXCL12-dependent vascular protection. Sci Signal.
2:ra812009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mattei AL, Bailly N and Meissner A: DNA
methylation: A historical perspective. Trends Genet. 38:676–707.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhu L, Zhu C, Wang J, Yang R and Zhao X:
The association between DNA methylation of 6p21.33 and AHRR in
blood and coronary heart disease in Chinese population. BMC
Cardiovasc Disord. 22:3702022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang Y, Yang R, Burwinkel B, Breitling
LP, Holleczek B, Schöttker B and Brenner H: F2RL3 methylation in
blood DNA is a strong predictor of mortality. Int J Epidemiol.
43:1215–1225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guarrera S, Fiorito G, Onland-Moret NC,
Russo A, Agnoli C, Allione A, Di Gaetano C, Mattiello A, Ricceri F,
Chiodini P, et al: Gene-specific DNA methylation profiles and
LINE-1 hypomethylation are associated with myocardial infarction
risk. Clin Epigenetics. 7:1332015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang W, Song M, Qu J and Liu GH:
Epigenetic modifications in cardiovascular aging and diseases. Circ
Res. 123:773–786. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nakamura TY, Iwata Y, Arai Y, Komamura K
and Wakabayashi S: Activation of Na+/H+ exchanger 1 is sufficient
to generate Ca2+ signals that induce cardiac hypertrophy and heart
failure. Circ Res. 103:891–899. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen S, Ma J, Chi J, Zhang B, Zheng X,
Chen J and Liu J: Roles and potential clinical implications of
tissue transglutaminase in cardiovascular diseases. Pharmacol Res.
177:1060852022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Westerman K, Sebastiani P, Jacques P, Liu
S, DeMeo D and Ordovás JM: DNA methylation modules associate with
incident cardiovascular disease and cumulative risk factor
exposure. Clin Epigenetics. 11:1422019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
GTEx Consortium; Laboratory, Data Analysis
& Coordinating Center (LDACC)-Analysis Working Group;
Statistical Methods groups-Analysis Working Group; Enhancing GTEx
(eGTEx) groups; NIH Common Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH;
NIH/NIDA; Biospecimen Collection Source Site-NDRI et al., . Genetic
effects on gene expression across human tissues. Nature.
550:204–213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Walaszczyk E, Luijten M, Spijkerman AMW,
Bonder MJ, Lutgers HL, Snieder H, Wolffenbuttel BHR and van
Vliet-Ostaptchouk JV: DNA methylation markers associated with type
2 diabetes, fasting glucose and HbA1c levels: A systematic review
and replication in a case-control sample of the Lifelines study.
Diabetol. 61:354–368. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Richard MA, Huan T, Ligthart S, Gondalia
R, Jhun MA, Brody JA, Irvin MR, Marioni R, Shen J, Tsai PC, et al:
DNA methylation analysis identifies loci for blood pressure
regulation. American. J Human Genet. 101:888–902. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kennel PJ, Liao X, Saha A, Ji R, Zhang X,
Castillero E, Brunjes D, Takayama H, Naka Y, Thomas T, et al:
Impairment of myocardial glutamine homeostasis induced by
suppression of the amino acid carrier SLC1A5 in failing myocardium.
Circ Heart Fail. 12:e0063362019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fernández-Sanlés A, Sayols-Baixeras S,
Curcio S, Subirana I, Marrugat J and Elosua R: DNA Methylation and
Age-independent cardiovascular risk, an Epigenome-wide approach:
The REGICOR study (REgistre GIroní del COR). Arterioscler Thromb
Vasc Biol. 38:645–652. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Guarrera S, Fiorito G, Onland-Moret NC,
Russo A, Agnoli C, Allione A, Di Gaetano C, Mattiello A, Ricceri F,
Chiodini P, et al: Gene-specific DNA methylation profiles and
LINE-1 hypomethylation are associated with myocardial infarction
risk. Clin Epigenetics. 7:1332015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shenker NS, Polidoro S, van Veldhoven K,
Sacerdote C, Ricceri F, Birrell MA, Belvisi MG, Brown R, Vineis P
and Flanagan JM: Epigenome-wide association study in the European
Prospective Investigation into Cancer and Nutrition (EPIC-Turin)
identifies novel genetic loci associated with smoking. Hum Mol
Genet. 22:843–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zaina S, Heyn H, Carmona FJ, Varol N,
Sayols S, Condom E, Ramírez-Ruz J, Gomez A, Gonçalves I, Moran S
and Esteller M: DNA methylation map of human atherosclerosis. Circ
Cardiovasc Genet. 7:692–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ligthart S, Marzi C, Aslibekyan S,
Mendelson MM, Conneely KN, Tanaka T, Colicino E, Waite LL, Joehanes
R, Guan W, et al: DNA methylation signatures of chronic low-grade
inflammation are associated with complex diseases. Genome Biol.
17:2552016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Navas-Acien A, Domingo-Relloso A, Subedi
P, Riffo-Campos AL, Xia R, Gomez L, Haack K, Goldsmith J, Howard
BV, Best LG, et al: Blood DNA methylation and incident coronary
heart disease: Evidence from the strong heart study. JAMA Cardiol.
6:1237–1246. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Luo X, Hu Y, Shen J, Liu X, Wang T, Li L
and Li J: Integrative analysis of DNA methylation and gene
expression reveals key molecular signatures in acute myocardial
infarction. Clin Epigenetics. 14:462022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yoshioka J, Imahashi K, Gabel SA, Chutkow
WA, Burds AA, Gannon J, Schulze PC, MacGillivray C, London RE,
Murphy E and Lee RT: Targeted deletion of thioredoxin-interacting
protein regulates cardiac dysfunction in response to pressure
overload. Circ Res. 101:1328–1338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Dorn LE, Lasman L, Chen J, Xu X, Hund TJ,
Medvedovic M, Hanna JH, van Berlo JH and Accornero F: The
N6-methyladenosine mRNA methylase METTL3 controls cardiac
homeostasis and hypertrophy. Circulation. 139:533–545. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yin T, Wang N, Jia F, Wu Y, Gao L, Zhang J
and Hou R: Exosome-based WTAP siRNA delivery ameliorates myocardial
ischemia-reperfusion injury. Eur J Pharm Biopharm. 197:1142182024.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Madsen A, Krause J, Höppner G, Hirt MN,
Tan WLW, Lim I, Hansen A, Nikolaev VO, Foo RSY, Eschenhagen T and
Stenzig J: Hypertrophic signaling compensates for contractile and
metabolic consequences of DNA methyltransferase 3A loss in human
cardiomyocytes. J Mol Cell Cardiol. 154:115–123. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Madsen A, Höppner G, Krause J, Hirt MN,
Laufer SD, Schweizer M, Tan WLW, Mosqueira D, Anene-Nzelu CG, Lim
I, et al: An important role for DNMT3A-Mediated DNA methylation in
cardiomyocyte metabolism and contractility. Circulation.
142:1562–1578. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Schiano C, Balbi C, Burrello J, Ruocco A,
Infante T, Fiorito C, Panella S, Barile L, Mauro C, Vassalli G and
Napoli C: De novo DNA methylation induced by circulating
extracellular vesicles from acute coronary syndrome patients.
Atherosclerosis. 354:41–52. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Fang X, Poulsen RR, Wang-Hu J, Shi O,
Calvo NS, Simmons CS, Rivkees SA and Wendler CC: Knockdown of DNA
methyltransferase 3a alters gene expression and inhibits function
of embryonic cardiomyocytes. FASEB J. 30:3238–3255. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Stenzig J, Schneeberger Y, Löser A, Peters
BS, Schaefer A, Zhao RR, Ng SL, Höppner G, Geertz B, Hirt MN, et
al: Pharmacological inhibition of DNA methylation attenuates
pressure overload-induced cardiac hypertrophy in rats. J Mol Cell
Cardiol. 120:53–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bomer N, Grote Beverborg N, Hoes MF,
Streng KW, Vermeer M, Dokter MM, IJmker J, Anker SD, Cleland JGF,
Hillege HL, et al: Selenium and outcome in heart failure. Eur J
Heart Fail. 22:1415–1423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhu H, Wang X, Meng X, Kong Y, Li Y, Yang
C, Guo Y, Wang X, Yang H, Liu Z and Wang F: Selenium
supplementation improved cardiac functions by suppressing
DNMT2-Mediated GPX1 Promoter DNA methylation in AGE-induced heart
failure. Oxid Med Cell Longev. 2022:54029972022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ramachandran B, Stabley JN, Cheng SL,
Behrmann AS, Gay A, Li L, Mead M, Kozlitina J, Lemoff A, Mirzaei H,
et al: A GTPase-activating protein-binding protein
(G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt
signals in aortic smooth muscle cells. J Biol Chem. 293:7942–7968.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Putra SED, Reichetzeder C, von Websky K,
Neuber C, Halle H, Kleuser B, Krämer BK and Hocher B: Association
between placental global DNA methylation and blood pressure during
human pregnancy. J Hypertens. 40:1002–1009. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Shao H, Chung J, Lee K, Balaj L, Min C,
Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R, et al:
Chip-based analysis of exosomal mRNA mediating drug resistance in
glioblastoma. Nat Commun. 6:69992015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yu W, Zhang L, Wei Q and Shao A:
O6-Methylguanine-DNA methyltransferase (MGMT): Challenges and new
opportunities in glioma chemotherapy. Front Oncol. 9:15472019.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cao YL, Zhuang T, Xing BH, Li N and Li Q:
Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer.
Cell Biochem Funct. 35:296–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chen M and Wong CM: The emerging roles of
N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol
Cancer. 19:442020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN,
Chen ZH, Zeng ZL, Wang F, Zheng J, et al: METTL3 facilitates tumor
progression via an mA-IGF2BP2-dependent mechanism in colorectal
carcinoma. Mol Cancer. 18:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Vu LP, Pickering BF, Cheng Y, Zaccara S,
Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M, et al:
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid
differentiation of normal hematopoietic and leukemia cells. Nat
Med. 23:1369–1376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Han M, Liu Z, Xu Y, Liu X, Wang D, Li F,
Wang Y and Bi J: Abnormality of m6A mRNA methylation is involved in
Alzheimer's disease. Front Neurosci. 14:982020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Fang J, Wu X, He J, Zhang H, Chen X, Zhang
H, Novakovic B, Qi H and Yu X: RBM15 suppresses hepatic insulin
sensitivity of offspring of gestational diabetes mellitus mice via
m6A-mediated regulation of CLDN4. Mol Med. 29:232023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Liu Y, Wang X, Huang M, Luo A, Liu S, Cai
M, Li W, Yuan S, Zheng Z, Liu X and Tang C: METTL3 facilitates
kidney injury through promoting IRF4-mediated plasma cell
infiltration via an m6A-dependent manner in systemic lupus
erythematosus. BMC Med. 22:5112024. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Henning RJ: Cardiovascular exosomes and
MicroRNAs in cardiovascular physiology and pathophysiology. J
Cardiovasc Transl Res. 14:195–212. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Boulanger CM, Loyer X, Rautou PE and
Amabile N: Extracellular vesicles in coronary artery disease. Nat
Rev Cardiol. 14:259–272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Waldenström A and Ronquist G: Role of
exosomes in myocardial remodeling. Circ Res. 114:315–324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lao KH, Zeng L and Xu Q: Endothelial and
smooth muscle cell transformation in atherosclerosis. Curr Opin
Lipidol. 26:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang Z, Gao D, Wang S, Lin H, Wang Y and
Xu W: Exosomal microRNA-1246 from human umbilical cord mesenchymal
stem cells potentiates myocardial angiogenesis in chronic heart
failure. Cell Biol Int. 45:2211–2225. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wu T, Chen Y, Du Y, Tao J, Li W, Zhou Z
and Yang Z: Circulating exosomal miR-92b-5p is a promising
diagnostic biomarker of heart failure with reduced ejection
fraction patients hospitalized for acute heart failure. J Thorac
Dis. 10:6211–6220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Wu T, Chen Y, Du Y, Tao J, Zhou Z and Yang
Z: Serum exosomal MiR-92b-5p as a potential biomarker for acute
heart failure caused by dilated cardiomyopathy. Cell Physiol
Biochem. 46:1939–1950. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wang L, Liu J, Xu B, Liu YL and Liu Z:
Reduced exosome miR-425 and miR-744 in the plasma represents the
progression of fibrosis and heart failure. Kaohsiung J Med Sci.
34:626–633. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Xie Y, Hang JZ, Zhang N and Liu G:
Clinical significance of MiR-27a expression in serum exosomes in
patients with heart failure. Cell Mol Biol (Noisy-le-grand).
67:324–331. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Natrus L, Labudzynskyi D, Muzychenko P,
Chernovol P and Klys Y: Plasma-derived exosomes implement
miR-126-associated regulation of cytokines secretion in PBMCs of
CHF patients in vitro. Acta Biomed. 93:e20220662022.PubMed/NCBI
|
|
102
|
Fuchs FD and Whelton PK: High blood
pressure and cardiovascular disease. Hypertension. 75:285–292.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Bress AP, Colantonio LD, Cooper RS, Kramer
H, Booth JN III, Odden MC, Bibbins-Domingo K, Shimbo D, Whelton PK,
Levitan EB, et al: Potential cardiovascular disease events
prevented with adoption of the 2017 American college of
Cardiology/American heart association blood pressure guideline.
Circulation. 139:24–36. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Gan L, Guo X, Dong S and Sun C: The
biology of exosomes and exosomal non-coding RNAs in cardiovascular
diseases. Front Pharmacol. 16:15293752025. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bhaskara M, Anjorin O and Wang M:
Mesenchymal stem Cell-derived exosomal microRNAs in cardiac
regeneration. Cells. 12:28152023. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Jayaseelan VP and Arumugam P: Exosomal
microRNAs as a promising theragnostic tool for essential
hypertension. Hypertens Res. 43:74–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ren XS, Tong Y, Qiu Y, Ye C, Wu N, Xiong
XQ, Wang JJ, Han Y, Zhou YB, Zhang F, et al: MiR155-5p in
adventitial fibroblasts-derived extracellular vesicles inhibits
vascular smooth muscle cell proliferation via suppressing
angiotensin-converting enzyme expression. J Extracell Vesicles.
9:16987952019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wu N, Ye C, Zheng F, Wan GW, Wu LL, Chen
Q, Li YH, Kang YM and Zhu GQ: MiR155-5p inhibits cell migration and
oxidative stress in vascular smooth muscle cells of spontaneously
hypertensive rats. Antioxidants (Basel). 9:2042020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zou X, Wang J, Chen C, Tan X, Huang Y,
Jose PA, Yang J and Zeng C: Secreted monocyte miR-27a, via
mesenteric arterial Mas receptor-eNOS pathway, causes hypertension.
Am J Hypertens. 33:31–42. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Osada-Oka M, Shiota M, Izumi Y, Nishiyama
M, Tanaka M, Yamaguchi T, Sakurai E, Miura K and Iwao H:
Macrophage-derived exosomes induce inflammatory factors in
endothelial cells under hypertensive conditions. Hypertens Res.
40:353–360. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Oh J, Matkovich SJ, Riek AE, Bindom SM,
Shao JS, Head RD, Barve RA, Sands MS, Carmeliet G, Osei-Owusu P, et
al: Macrophage secretion of miR-106b-5p causes renin-dependent
hypertension. Nat Commun. 11:47982020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Rodosthenous RS, Kloog I, Colicino E,
Zhong J, Herrera LA, Vokonas P, Schwartz J, Baccarelli AA and Prada
D: Extracellular vesicle-enriched microRNAs interact in the
association between long-term particulate matter and blood pressure
in elderly men. Environ Res. 167:640–649. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Ren Y and Zhang H: Emerging role of
exosomes in vascular diseases. Front Cardiovasc Med.
10:10909092023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Chen L, Hu L, Li Q, Ma J and Li H:
Exosome-encapsulated miR-505 from ox-LDL-treated vascular
endothelial cells aggravates atherosclerosis by inducing NET
formation. Acta Biochim Biophys Sin (Shanghai). 51:1233–1241. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Shaheen N, Shaheen A, Diab RA and Desouki
MT: MicroRNAs (miRNAs) role in hypertension: Pathogenesis and
promising therapeutics. Ann Med Surg (Lond). 86:319–328. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Han J, Kang X, Su Y, Wang J, Cui X, Bian Y
and Wu C: Plasma exosomes from patients with coronary artery
disease promote atherosclerosis via impairing vascular endothelial
junctions. Sci Rep. 14:298132024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Guo B, Zhuang TT, Li CC, Li F, Shan SK,
Zheng MH, Xu QS, Wang Y, Lei LM, Tang KX, et al: MiRNA-132/212
encapsulated by adipose tissue-derived exosomes Worsen
atherosclerosis progression. Cardiovasc Diabetol. 23:3312024.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wehbe Z, Wehbe M, Al Khatib A, Dakroub AH,
Pintus G, Kobeissy F and Eid AH: Emerging understandings of the
role of exosomes in atherosclerosis. J Cell Physiol.
240:e314542025. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Xu S, Ilyas I, Little PJ, Li H, Kamato D,
Zheng X, Luo S, Li Z, Liu P, Han J, et al: Endothelial dysfunction
in atherosclerotic cardiovascular diseases and beyond: From
mechanism to pharmacotherapies. Pharmacol Rev. 73:924–967. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Alidadi M, Hjazi A, Ahmad I, Mahmoudi R,
Sarrafha M, Reza Hosseini-Fard S and Ebrahimzade M: Exosomal
non-coding RNAs: Emerging therapeutic targets in atherosclerosis.
Biochem Pharmacol. 212:1155722023. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Li L, Wang Z, Hu X, Wan T, Wu H, Jiang W
and Hu R: Human aortic smooth muscle cell-derived exosomal
miR-221/222 inhibits autophagy via a PTEN/Akt signaling pathway in
human umbilical vein endothelial cells. Biochem Biophys Res Commun.
479:343–350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Li J, Tan M, Xiang Q, Zhou Z and Yan H:
Thrombin-activated platelet-derived exosomes regulate endothelial
cell expression of ICAM-1 via microRNA-223 during the
thrombosis-inflammation response. Thromb Res. 154:96–105. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhong X, Gao W, Wu R, Liu H and Ge J:
Dendritic cell exosome-shuttled miRNA146a regulates exosome-induced
endothelial cell inflammation by inhibiting IRAK-1: A feedback
control mechanism. Mol Med Rep. 20:5315–5323. 2019.PubMed/NCBI
|
|
124
|
Liu P, Wang S, Wang G, Zhao M, Du F, Li K,
Wang L, Wu H, Chen J, Yang Y and Su G: Macrophage-derived exosomal
miR-4532 promotes endothelial cells injury by targeting SP1 and
NF-κB P65 signalling activation. J Cell Mol Med. 26:5165–5180.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zheng B, Yin WN, Suzuki T, Zhang XH, Zhang
Y, Song LL, Jin LS, Zhan H, Zhang H, Li JS and Wen JK:
Exosome-Mediated miR-155 transfer from smooth muscle cells to
endothelial cells induces endothelial injury and promotes
atherosclerosis. Mol Ther. 25:1279–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Loyer X, Potteaux S, Vion AC, Guérin CL,
Boulkroun S, Rautou PE, Ramkhelawon B, Esposito B, Dalloz M, Paul
JL, et al: Inhibition of microRNA-92a prevents endothelial
dysfunction and atherosclerosis in mice. Circ Res. 114:434–443.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Masson JJR, Cherry CL, Murphy NM,
Sada-Ovalle I, Hussain T, Palchaudhuri R, Martinson J, Landay AL,
Billah B, Crowe SM and Palmer CS: Polymorphism rs1385129 Within
Glut1 Gene SLC2A1 is linked to poor CD4+ T cell recovery in
Antiretroviral-Treated HIV+ individuals. Front Immunol. 9:9002018.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lee MA, Raad N, Song MH, Yoo J, Lee M,
Jang SP, Kwak TH, Kook H, Choi EK, Cha TJ, et al: The matricellular
protein CCN5 prevents adverse atrial structural and electrical
remodelling. J Cell Mol Med. 24:11768–11778. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Stamatikos A, Knight E, Vojtech L, Bi L,
Wacker BK, Tang C and Dichek DA: Exosome-mediated transfer of
Anti-miR-33a-5p from transduced endothelial cells enhances
macrophage and vascular smooth muscle cell cholesterol efflux. Hum
Gene Ther. 31:219–232. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Chen F, Li J, She J, Chen T and Yuan Z:
Exosomal microRNA-16-5p from macrophage exacerbates atherosclerosis
via modulating mothers against decapentaplegic homolog 7. Microvasc
Res. 142:1043682022. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wang G, Li Y, Liu Z, Ma X, Li M, Lu Q, Li
Y, Lu Z, Niu L, Fan Z and Lei Z: Circular RNA circ_0124644
exacerbates the ox-LDL-induced endothelial injury in human vascular
endothelial cells through regulating PAPP-A by acting as a sponge
of miR-149-5p. Mol Cell Biochem. 471:51–61. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Lin B, Xie W, Zeng C, Wu X, Chen A, Li H,
Jiang R and Li P: Transfer of exosomal microRNA-203-3p from
dendritic cells to bone marrow-derived macrophages reduces
development of atherosclerosis by downregulating Ctss in mice.
Aging (Albany NY). 13:15638–15658. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Adamidis PS, Pantazi D, Moschonas IC,
Liberopoulos E and Tselepis AD: Neutrophil extracellular traps
(NETs) and atherosclerosis: Does hypolipidemic treatment have an
effect? J Cardiovasc Dev Dis. 11:722024.PubMed/NCBI
|
|
134
|
Sano M, Maejima Y, Nakagama S,
Shiheido-Watanabe Y, Tamura N, Hirao K, Isobe M and Sasano T:
Neutrophil extracellular traps-mediated Beclin-1 suppression
aggravates atherosclerosis by inhibiting macrophage autophagy.
Front Cell Dev Biol. 10:8761472022. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Brinkmann V, Reichard U, Goosmann C,
Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A:
Neutrophil extracellular traps kill bacteria. Science.
303:1532–1535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhang YG, Song Y, Guo XL, Miao RY, Fu YQ,
Miao CF and Zhang C: Exosomes derived from oxLDL-stimulated
macrophages induce neutrophil extracellular traps to drive
atherosclerosis. Cell Cycle. 18:2674–268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wang X, Li D, Chen H, Wei X and Xu X:
Expression of Long Noncoding RNA LIPCAR promotes cell
proliferation, cell migration, and change in phenotype of vascular
smooth muscle cells. Med Sci Monit. 25:7645–7651. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Hu N, Zeng X, Tang F and Xiong S: Exosomal
long non-coding RNA LIPCAR derived from oxLDL-treated THP-1 cells
regulates the proliferation of human umbilical vein endothelial
cells and human vascular smooth muscle cells. Biochem Biophys Res
Commun. 575:65–72. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Liu Y, Zhang WL, Gu JJ, Sun YQ, Cui HZ, Bu
JQ and Chen ZY: Exosome-mediated miR-106a-3p derived from ox-LDL
exposed macrophages accelerated cell proliferation and repressed
cell apoptosis of human vascular smooth muscle cells. Eur Rev Med
Pharmacol Sci. 24:7039–7050. 2020.PubMed/NCBI
|
|
140
|
Zhang Z, Yi D, Zhou J, Zheng Y, Gao Z, Hu
X, Ying G, Peng X and Wen T: Exosomal LINC01005 derived from
oxidized low-density lipoprotein-treated endothelial cells
regulates vascular smooth muscle cell phenotypic switch.
Biofactors. 46:743–753. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Chen L, Yang W, Guo Y, Chen W, Zheng P,
Zeng J and Tong W: Exosomal lncRNA GAS5 regulates the apoptosis of
macrophages and vascular endothelial cells in atherosclerosis. PLoS
One. 12:e01854062017. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Huang C, Han J, Wu Y, Li S, Wang Q, Lin W
and Zhu J: Exosomal MALAT1 derived from oxidized low-density
lipoprotein-treated endothelial cells promotes M2 macrophage
polarization. Mol Med Rep. 18:509–515. 2018.PubMed/NCBI
|
|
143
|
Gao H, Wang X, Lin C, An Z, Yu J, Cao H,
Fan Y and Liang X: Exosomal MALAT1 derived from ox-LDL-treated
endothelial cells induce neutrophil extracellular traps to
aggravate atherosclerosis. Biol Chem. 401:367–376. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Wen Y, Chun Y, Lian ZQ, Yong ZW, Lan YM,
Huan L, Xi CY, Juan LS, Qing ZW, Jia C and Ji ZH:
circRNA-0006896-miR1264-DNMT1 axis plays an important role in
carotid plaque destabilization by regulating the behavior of
endothelial cells in atherosclerosis. Mol Med Rep. 23:3112021.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Lu Z, Tang H, Li S, Zhu S, Li S and Huang
Q: Role of circulating exosomes in cerebrovascular diseases: A
comprehensive review. Curr Neuropharmacol. 21:1575–1593. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Yu Z, Huang Q, Zhang Q, Wu H and Zhong Z:
CircRNAs open a new era in the study of cardiovascular disease
(review). Int J Mol Med. 47:49–64. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhang P, Liang T, Wang X, Wu T, Xie Z, Yu
Y and Yu H: Serum-derived exosomes from patients with coronary
artery disease induce endothelial injury and inflammation in human
umbilical vein endothelial cells. Int Heart J. 62:396–406. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Zarà M, Campodonico J, Cosentino N, Biondi
ML, Amadio P, Milanesi G, Assanelli E, Cerri S, Biggiogera M,
Sandrini L, et al: Plasma exosome profile in ST-Elevation
myocardial infarction patients with and without Out-of-Hospital
cardiac arrest. Int J Mol Sci. 22:80652021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Tong X, Dang X, Liu D, Wang N, Li M, Han
J, Zhao J, Wang Y, Huang M, Yang Y, et al: Exosome-derived
circ_0001785 delays atherogenesis through the ceRNA network
mechanism of miR-513a-5p/TGFBR3. J Nanobiotechnology. 21:3622023.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Byrne RA, Rossello X, Coughlan JJ, Barbato
E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et
al: 2023 ESC Guidelines for the management of acute coronary
syndromes. Eur Heart J. 44:3720–382. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ong SG, Lee WH, Huang M, Dey D, Kodo K,
Sanchez-Freire V, Gold JD and Wu JC: Cross talk of combined gene
and cell therapy in ischemic heart disease: role of exosomal
microRNA transfer. Circulation. 130 (Suppl 1):S60–S69. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Saparov A, Ogay V, Nurgozhin T, Chen WCW,
Mansurov N, Issabekova A and Zhakupova J: Role of the immune system
in cardiac tissue damage and repair following myocardial
infarction. Inflamm Res. 66:739–751. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li Y, Yang R, Guo B, Zhang H, Zhang H, Liu
S and Li Y: Exosomal miR-301 derived from mesenchymal stem cells
protects myocardial infarction by inhibiting myocardial autophagy.
Biochem Biophys Res Commun. 514:323–332. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
De Rosa S, Fichtlscherer S, Lehmann R,
Assmus B, Dimmeler S and Zeiher AM: Transcoronary concentration
gradients of circulating microRNAs. Circulation. 124:1936–1944.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Peng Y, Zhao JL, Peng ZY, Xu WF and Yu GL:
Exosomal miR-25-3p from mesenchymal stem cells alleviates
myocardial infarction by targeting pro-apoptotic proteins and EZH2.
Cell Death Dis. 11:3172020. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Wang W, Zheng Y, Wang M, Yan M, Jiang J
and Li Z: Exosomes derived miR-126 attenuates oxidative stress and
apoptosis from ischemia and reperfusion injury by targeting ERRFI1.
Gene. 690:75–80. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Pan J, Alimujiang M, Chen Q, Shi H and Luo
X: Exosomes derived from miR-146a-modified adipose-derived stem
cells attenuate acute myocardial infarction-induced myocardial
damage via downregulation of early growth response factor 1. J Cell
Biochem. 120:4433–4443. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Li H, Ding J, Liu W, Wang X, Feng Y, Guan
H and Chen Z: Plasma exosomes from patients with acute myocardial
infarction alleviate myocardial injury by inhibiting ferroptosis
through miR-26b-5p/SLC7A11 axis. Life Sci. 322:1216492023.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Feng Y, Huang W, Wani M, Yu X and Ashraf
M: Ischemic preconditioning potentiates the protective effect of
stem cells through secretion of exosomes by targeting Mecp2 via
miR-22. PLoS One. 9:e886852014. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang J, Huang W, Xu R, Nie Y, Cao X, Meng
J, Xu X, Hu S and Zheng Z: MicroRNA-24 regulates cardiac fibrosis
after myocardial infarction. J Cell Mol Med. 16:2150–2160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wang K, Jiang Z, Webster KA, Chen J, Hu H,
Zhou Y, Zhao J, Wang L, Wang Y, Zhong Z, et al: Enhanced
Cardioprotection by human endometrium mesenchymal stem cells driven
by exosomal MicroRNA-21. Stem Cells Transl Med. 6:209–222. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Liao B, Dong S, Xu Z, Gao F, Zhang S and
Liang R: MiR-19b-3p regulated by BC002059/ABHD10 axis promotes cell
apoptosis in myocardial infarction. Biol Direct. 17:202022.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Shyu KG, Wang BW, Fang WJ, Pan CM and Lin
CM: Hyperbaric oxygen-induced long non-coding RNA MALAT1 exosomes
suppress MicroRNA-92a expression in a rat model of acute myocardial
infarction. J Cell Mol Med. 24:12945–12954. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Huang P, Wang L, Li Q, Tian X, Xu J, Xu J,
Xiong Y, Chen G, Qian H, Jin C, et al: Atorvastatin enhances the
therapeutic efficacy of mesenchymal stem cells-derived exosomes in
acute myocardial infarction via up-regulating long non-coding RNA
H19. Cardiovasc Res. 116:353–367. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang L and Zhang J: Exosomal lncRNA
AK139128 Derived from hypoxic cardiomyocytes promotes apoptosis and
inhibits cell proliferation in cardiac fibroblasts. Int J
Nanomedicine. 15:3363–3376. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Cheng M, Yang J, Zhao X, Zhang E, Zeng Q,
Yu Y, Yang L, Wu B, Yi G, Mao X, et al: Circulating myocardial
microRNAs from infarcted hearts are carried in exosomes and
mobilise bone marrow progenitor cells. Nat Commun. 10:9592019.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Huang P, Wang L, Li Q, Tian X, Xu J, Xu J,
Xiong Y, Chen G, Qian H, Jin C, et al: Atorvastatin enhances the
therapeutic efficacy of mesenchymal stem cells-derived exosomes in
acute myocardial infarction via up-regulating long non-coding RNA
H19. Cardiovasc Res. 116:353–367. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zhang Y, Liu Y, Liu H and Tang WH:
Exosomes: Biogenesis, biologic function and clinical potential.
Cell Biosci. 9:192019. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Xu H, Du X, Xu J, Zhang Y, Tian Y, Liu G,
Wang X, Ma M, Du W, Liu Y, et al: Pancreatic β cell microRNA-26a
alleviates type 2 diabetes by improving peripheral insulin
sensitivity and preserving β cell function. PLoS Biol.
18:e30006032020. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Fu Q, Jiang H, Wang Z, Wang X, Chen H,
Shen Z, Xiao L, Guo X and Yang T: Injury factors alter miRNAs
profiles of exosomes derived from islets and circulation. Aging
(Albany NY). 10:3986–3999. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
da Costa Martins PA, Bourajjaj M, Gladka
M, Kortland M, van Oort RJ, Pinto YM, Molkentin JD and De Windt LJ:
Conditional dicer gene deletion in the postnatal myocardium
provokes spontaneous cardiac remodeling. Circulation.
118:1567–1576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Chen JF, Murchison EP, Tang R, Callis TE,
Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD and Selzman
CH: Targeted deletion of Dicer in the heart leads to dilated
cardiomyopathy and heart failure. Proc Natl Acad Sci USA.
105:2111–2116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Liang Y, Duan L, Lu J and Xia J:
Engineering exosomes for targeted drug delivery. Theranostics.
11:3183–3195. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Vader P, Mol EA, Pasterkamp G and
Schiffelers RM: Extracellular vesicles for drug delivery. Adv Drug
Deliv Rev. 106:148–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
O'Brien K, Breyne K, Ughetto S, Laurent LC
and Breakefield XO: RNA delivery by extracellular vesicles in
mammalian cells and its applications. Nat Rev Mol Cell Biol.
21:585–606. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Liu Y, Wang M, Yu Y, Li C and Zhang C:
Advances in the study of exosomes derived from mesenchymal stem
cells and cardiac cells for the treatment of myocardial infarction.
Cell Commun Signal. 21:2022023. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Das D, Jothimani G, Banerjee A, Dey A,
Duttaroy AK and Pathak S: A brief review on recent advances in
diagnostic and therapeutic applications of extracellular vesicles
in cardiovascular disease. Int J Biochem Cell Biol. 173:1066162024.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Li Z, Zhao P, Zhang Y, Wang J, Wang C, Liu
Y, Yang G and Yuan L: Exosome-based Ldlr gene therapy for familial
hypercholesterolemia in a mouse model. Theranostics. 11:2953–2965.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Huang L, Yang L, Ding Y, Jiang X, Xia Z
and You Z: Human umbilical cord mesenchymal stem cells-derived
exosomes transfers microRNA-19a to protect cardiomyocytes from
acute myocardial infarction by targeting SOX6. Cell Cycle.
19:339–353. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Li Y, Zhou J, Zhang O, Wu X, Guan X, Xue
Y, Li S, Zhuang X, Zhou B, Miao G and Zhang L: Bone marrow
mesenchymal stem cells-derived exosomal microRNA-185 represses
ventricular remolding of mice with myocardial infarction by
inhibiting SOCS2. Int Immunopharmacol. 80:1061562020. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X,
Gao L, Xie J and Xu B: Mesenchymal stromal cell-derived exosomes
attenuate myocardial ischaemia-reperfusion injury through
miR-182-regulated macrophage polarization. Cardiovasc Res.
115:1205–1216. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Liu Y, Li C, Wu H, Xie X, Sun Y and Dai M:
Paeonol attenuated inflammatory response of endothelial cells via
stimulating Monocytes-Derived exosomal MicroRNA-223. Front
Pharmacol. 9:11052018. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Schena GJ, Murray EK, Hildebrand AN,
Headrick AL, Yang Y, Koch KA, Kubo H, Eaton D, Johnson J, Berretta
R, et al: Cortical bone stem cell-derived exosomes' therapeutic
effect on myocardial ischemia-reperfusion and cardiac remodeling.
Am J Physiol Heart Circ Physiol. 321:H1014–H1029. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lin CM, Wang BW, Pan CM, Fang WJ, Chua SK,
Cheng WP and Shyu KG: Chrysin boosts KLF2 expression through
suppression of endothelial cell-derived exosomal microRNA-92a in
the model of atheroprotection. Eur J Nutr. 60:4345–4355. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Zhu J, Liu B, Wang Z, Wang D, Ni H, Zhang
L and Wang Y: Exosomes from nicotine-stimulated macrophages
accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC
migration and proliferation. Theranostics. 9:6901–6919. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Bergmann O, Bhardwaj RD, Bernard S, Zdunek
S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA,
Druid H, et al: Evidence for cardiomyocyte renewal in humans.
Science. 324:98–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Smith RR, Barile L, Cho HC, Leppo MK, Hare
JM, Messina E, Giacomello A, Abraham MR and Marbán E: Regenerative
potential of cardiosphere-derived cells expanded from percutaneous
endomyocardial biopsy specimens. Circulation. 115:896–908. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Teerlink JR, Metra M, Filippatos GS,
Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD,
Alexandre B, et al: Benefit of cardiopoietic mesenchymal stem cell
therapy on left ventricular remodelling: Results from the
congestive heart failure cardiopoietic regenerative therapy
(CHART-1) study. Eur J Heart Fail. 19:1520–1529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Bartunek J, Terzic A, Behfar A and Wijns
W: Clinical experience with regenerative therapy in heart failure:
Advancing care with cardiopoietic stem cell interventions. Circ
Res. 122:1344–1346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Wang Y, Zhao M, Liu S, Guo J, Lu Y, Cheng
J and Liu J: Macrophage-derived extracellular vesicles: Diverse
mediators of pathology and therapeutics in multiple diseases. Cell
Death Dis. 11:9242020. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
EL Andaloussi S, Mäger I, Breakefield XO
and Wood MJ: Extracellular vesicles: Biology and emerging
therapeutic opportunities. Nat Rev Drug Discov. 12:347–357. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Sun D, Zhuang X, Xiang X, Liu Y, Zhang S,
Liu C, Barnes S, Grizzle W, Miller D and Zhang HG: A Novel
nanoparticle drug delivery system: The Anti-inflammatory activity
of curcumin is enhanced when encapsulated in exosomes. Mol Ther.
18:1606–1614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Sherman LS, Shaker M, Mariotti V and
Rameshwar P: Mesenchymal stromal/stem cells in drug therapy: New
perspective. Cytotherapy. 19:19–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Ubanako P, Mirza S, Ruff P and Penny C:
Exosome-mediated delivery of siRNA molecules in cancer therapy:
Triumphs and challenges. Front Mol Biosci. 11:14479532024.
View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Sun L, Xu R, Sun X, Duan Y, Han Y, Zhao Y,
Qian H, Zhu W and Xu W: Safety evaluation of exosomes derived from
human umbilical cord mesenchymal stromal cell. Cytotherapy.
18:413–422. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Fu W, Li T, Chen H, Zhu S and Zhou C:
Research progress in Exosome-based nanoscale drug carriers in tumor
therapies. Front Oncol. 12:9192792022. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Smyth T, Kullberg M, Malik N, Smith-Jones
P, Graner MW and Anchordoquy TJ: Biodistribution and delivery
efficiency of unmodified tumor-derived exosomes. J Control Release.
199:145–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Frolova L and Li ITS: Targeting
capabilities of native and bioengineered extracellular vesicles for
drug delivery. Bioengineering (Basel). 9:4962022. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Jeyaram A, Lamichhane TN, Wang S, Zou L,
Dahal E, Kronstadt SM, Levy D, Parajuli B, Knudsen DR, Chao W and
Jay SM: Enhanced loading of functional miRNA cargo via pH gradient
modification of extracellular vesicles. Mol Ther. 28:975–985. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Perocheau D, Touramanidou L, Gurung S,
Gissen P and Baruteau J: Clinical applications for exosomes: Are we
there yet? Br J Pharmacol. 178:2375–2392. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Lamparski HG, Methadamani A, Yao JY, Patel
S, Hsu DH, Ruegg C and Le PJ: Production and characterization of
clinical grade exosomes derived from dendritic cells. J Immunol
Methods. 270:211–226. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Liu Y, Li D, Liu Z, Zhou Y, Chu D, Li X,
Jiang X, Hou D, Chen X and Chen Y: Targeted exosome-mediated
delivery of opioid receptor Mu siRNA for the treatment of morphine
relapse. Sci Rep. 5:175432015. View Article : Google Scholar : PubMed/NCBI
|
